| 查看: 354 | 回复: 3 | |||
| 当前主题已经存档。 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
bioinfuture铁虫 (小有名气)
|
[交流]
急需一篇SCI文章，必有金币酬谢
|
||
|
1: Immunol Res. 1998;18(2):79-92.Links The optimization of helper T lymphocyte (HTL) function in vaccine development.Alexander J, Fikes J, Hoffman S, Franke E, Sacci J, Appella E, Chisari FV, Guidotti LG, Chesnut RW, Livingston B, Sette A. Epimmune Inc., San Diego, CA, USA. Helper T lymphocyte (HTL) responses play an important role in the induction of both humoral and cellular immune responses. Therefore, HTL epitopes are likely to be a crucial component of prophylactic and immunotherapeutic vaccines. For this reason, Pan DR helper T cell epitopes (PADRE), engineered to bind most common HLA-DR molecules with high affinity and act as powerful immunogens, were developed. Short linear peptide constructs comprising PADRE and Plasmodium-derived B cell epitopes induced antibody responses comparable to more complex multiple antigen peptides (MAP) constructs in mice. These antibody responses were composed mostly of the IgG subclass, reactive against intact sporozoites, inhibitory of schizont formation in liver invasion assays, and protective against sporozoite challenge in vivo. The PADRE HTL epitope has also been shown to augment the potency of vaccines designed to stimulate a cellular immune response. Using a HBV transgenic murine model, it was found that CTL tolerance was broken by PADRE-CTL epitope lipopeptide, but not by a similar construct containing a conventional HTL epitope. There are a number of prophylactic vaccines that are of limited efficacy, require multiple boosts, and/or confer protection to only a fraction of the immunized population. Also, in the case of virally infected or cancerous cells, new immunotherapeutic vaccines that induce strong cellular immune responses are desirable. Therefore, optimization of HTL function by use of synthetic epitopes such as PADRE or pathogen-derived, broadly crossreactive epitopes holds promise for a new generation of highly efficacious vaccines. |
回复此楼» 猜你喜欢
08工学调剂
已经有16人回复
-
0703化学调剂，求导师收
已经有7人回复
-
0854AI CV方向招收调剂
已经有3人回复
-
求调剂323材料与化工
已经有3人回复
-
生物学学硕求调剂
已经有9人回复
-
289求调剂
已经有8人回复
-
07化学280分求调剂
已经有5人回复
-
300分，材料，求调剂，英一数二
已经有4人回复
-
【考研调剂】化学专业 281分，一志愿四川大学，诚心求调剂
已经有16人回复
-
0854电子信息求调剂
已经有7人回复
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
bioinfuture(金币+15,VIP+0): 8-21 14:49
bioinfuture(金币+15,VIP+0): 8-21 14:49
| 已发送至你的邮箱shengmingbuxi@yahoo.com.cn。 |
3楼2009-08-21 14:45:41
houjinglhy
荣誉版主 (文坛精英)
表达自由，人权之基。
- BioEPI: 1
- 应助: 21 (小学生)
- 贵宾: 0.911
- 金币: 5168.5
- 散金: 3205
- 红花: 137
- 沙发: 93
- 帖子: 10564
- 在线: 913.2小时
- 虫号: 461324
- 注册: 2007-11-18
- 专业: 生物技术药物
- 管辖: 公派出国
★ ★ ★ ★ ★
bioinfuture(金币+5,VIP+0):xiexie 8-21 14:48
bioinfuture(金币+5,VIP+0):xiexie 8-21 14:48
2楼2009-08-21 00:05:18
5